Literature DB >> 8163277

Hemangiopericytoma of the tongue in a 12-year-old child: ultrastructural and cytogenetic observations.

A R Perez-Atayde1, H W Kozakewich, T McGill, J A Fletcher.   

Abstract

We report a case of hemangiopericytoma arising from the tongue of a 12-year-old child. Ultrastructurally, tumor cells revealed discontinuous basal lamina, intermediate-type intercellular junctions, subplasmalemmal thickenings, and smooth muscle-type cytoplasmic filaments. In addition, occasional oligocilia and test tube-like inclusions were observed. Karyotypic analysis of the tumor cells revealed two balanced translocations that have not been reported previously in pediatric solid tumors: one involved chromosomes 1 and 3, t(1;3)(p22;q21), and the other involved chromosomes 7 and 12, t(7;12)(p22;q13). This is the first report of cytogenetic aberrations in a pediatric hemangiopericytoma. Correlation with genetic findings in adult hemangiopericytomas suggests that the chromosome 12q13 rearrangement might be of particular importance.

Entities:  

Mesh:

Year:  1994        PMID: 8163277     DOI: 10.1016/0046-8177(94)90155-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

1.  Pericytoma With t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms.

Authors:  Darcy A Kerr; Andre Pinto; Ty K Subhawong; Breelyn A Wilky; Matthew P Schlumbrecht; Cristina R Antonescu; G Petur Nielsen; Andrew E Rosenberg
Journal:  Am J Surg Pathol       Date:  2019-12       Impact factor: 6.394

2.  Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).

Authors:  Anna Dahlén; Christopher D M Fletcher; Fredrik Mertens; Jonathan A Fletcher; Antonio R Perez-Atayde; M John Hicks; Maria Debiec-Rychter; Raf Sciot; Johan Wejde; Rikard Wedin; Nils Mandahl; Ioannis Panagopoulos
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.